BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25981510)

  • 1. Whole-Genome Sequencing and Integrative Genomic Analysis Approach on Two 22q11.2 Deletion Syndrome Family Trios for Genotype to Phenotype Correlations.
    Chung JH; Cai J; Suskin BG; Zhang Z; Coleman K; Morrow BE
    Hum Mutat; 2015 Aug; 36(8):797-807. PubMed ID: 25981510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-Wide Association Study to Find Modifiers for Tetralogy of Fallot in the 22q11.2 Deletion Syndrome Identifies Variants in the
    Guo T; Repetto GM; McDonald McGinn DM; Chung JH; Nomaru H; Campbell CL; Blonska A; Bassett AS; Chow EWC; Mlynarski EE; Swillen A; Vermeesch J; Devriendt K; Gothelf D; Carmel M; Michaelovsky E; Schneider M; Eliez S; Antonarakis SE; Coleman K; Tomita-Mitchell A; Mitchell ME; Digilio MC; Dallapiccola B; Marino B; Philip N; Busa T; Kushan-Wells L; Bearden CE; Piotrowicz M; Hawuła W; Roberts AE; Tassone F; Simon TJ; van Duin EDA; van Amelsvoort TA; Kates WR; Zackai E; Johnston HR; Cutler DJ; Agopian AJ; Goldmuntz E; Mitchell LE; Wang T; Emanuel BS; Morrow BE;
    Circ Cardiovasc Genet; 2017 Oct; 10(5):e001690. PubMed ID: 29025761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype and cardiovascular phenotype correlations with TBX1 in 1,022 velo-cardio-facial/DiGeorge/22q11.2 deletion syndrome patients.
    Guo T; McDonald-McGinn D; Blonska A; Shanske A; Bassett AS; Chow E; Bowser M; Sheridan M; Beemer F; Devriendt K; Swillen A; Breckpot J; Digilio MC; Marino B; Dallapiccola B; Carpenter C; Zheng X; Johnson J; Chung J; Higgins AM; Philip N; Simon TJ; Coleman K; Heine-Suner D; Rosell J; Kates W; Devoto M; Goldmuntz E; Zackai E; Wang T; Shprintzen R; Emanuel B; Morrow B;
    Hum Mutat; 2011 Nov; 32(11):1278-89. PubMed ID: 21796729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overt cleft palate phenotype and TBX1 genotype correlations in velo-cardio-facial/DiGeorge/22q11.2 deletion syndrome patients.
    Herman SB; Guo T; McGinn DM; Blonska A; Shanske AL; Bassett AS; Chow EW; Bowser M; Sheridan M; Beemer F; Devriendt K; Swillen A; Breckpot J; Digilio MC; Marino B; Dallapiccola B; Carpenter C; Zheng X; Johnson J; Chung J; Higgins AM; Philip N; Simon T; Coleman K; Heine-Suner D; Rosell J; Kates W; Devoto M; Zackai E; Wang T; Shprintzen R; Emanuel BS; Morrow BE;
    Am J Med Genet A; 2012 Nov; 158A(11):2781-7. PubMed ID: 23034814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No evidence for the presence of genetic variants predisposing to psychotic disorders on the non-deleted 22q11.2 allele of VCFS patients.
    Guipponi M; Santoni F; Schneider M; Gehrig C; Bustillo XB; Kates WR; Morrow B; Armando M; Vicari S; Sloan-Béna F; Gagnebin M; Shashi V; Hooper SR; Eliez S; Antonarakis SE
    Transl Psychiatry; 2017 Feb; 7(2):e1039. PubMed ID: 28221368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variant discovery and breakpoint region prediction for studying the human 22q11.2 deletion using BAC clone and whole genome sequencing analysis.
    Guo X; Delio M; Haque N; Castellanos R; Hestand MS; Vermeesch JR; Morrow BE; Zheng D
    Hum Mol Genet; 2016 Sep; 25(17):3754-3767. PubMed ID: 27436579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candidate genes and the behavioral phenotype in 22q11.2 deletion syndrome.
    Prasad SE; Howley S; Murphy KC
    Dev Disabil Res Rev; 2008; 14(1):26-34. PubMed ID: 18636634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-Genome Sequencing Suggests Schizophrenia Risk Mechanisms in Humans with 22q11.2 Deletion Syndrome.
    Merico D; Zarrei M; Costain G; Ogura L; Alipanahi B; Gazzellone MJ; Butcher NJ; Thiruvahindrapuram B; Nalpathamkalam T; Chow EW; Andrade DM; Frey BJ; Marshall CR; Scherer SW; Bassett AS
    G3 (Bethesda); 2015 Sep; 5(11):2453-61. PubMed ID: 26384369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome].
    Demily C; Rossi M; Schneider M; Edery P; Leleu A; d'Amato T; Franck N; Eliez S
    Encephale; 2015 Jun; 41(3):266-73. PubMed ID: 25523123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome.
    Bassett AS; Marshall CR; Lionel AC; Chow EW; Scherer SW
    Hum Mol Genet; 2008 Dec; 17(24):4045-53. PubMed ID: 18806272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome.
    Paylor R; Glaser B; Mupo A; Ataliotis P; Spencer C; Sobotka A; Sparks C; Choi CH; Oghalai J; Curran S; Murphy KC; Monks S; Williams N; O'Donovan MC; Owen MJ; Scambler PJ; Lindsay E
    Proc Natl Acad Sci U S A; 2006 May; 103(20):7729-34. PubMed ID: 16684884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DiGeorge syndrome: new insights.
    Goldmuntz E
    Clin Perinatol; 2005 Dec; 32(4):963-78, ix-x. PubMed ID: 16325672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3 generation pedigree with paternal transmission of the 22q11.2 deletion syndrome: Intrafamilial phenotypic variability.
    Vergaelen E; Swillen A; Van Esch H; Claes S; Van Goethem G; Devriendt K
    Eur J Med Genet; 2015 Apr; 58(4):244-8. PubMed ID: 25655469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome.
    Gothelf D; Feinstein C; Thompson T; Gu E; Penniman L; Van Stone E; Kwon H; Eliez S; Reiss AL
    Am J Psychiatry; 2007 Apr; 164(4):663-9. PubMed ID: 17403981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of deletion breakpoints in adults with 22q11 deletion syndrome.
    Weksberg R; Stachon AC; Squire JA; Moldovan L; Bayani J; Meyn S; Chow E; Bassett AS
    Hum Genet; 2007 Feb; 120(6):837-45. PubMed ID: 17028864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variants in Candidate Genes for Phenotype Heterogeneity in Patients with the 22q11.2 Deletion Syndrome.
    Nunes N; Carvalho Nunes B; Zamariolli M; Cordeiro de Queiroz Soares D; Caires Dos Santos L; Gollo Dantas A; Ayres Meloni V; Iole Belangero S; Gil-Da-Silva-Lopes VL; Ae Kim C; Melaragno MI
    Genet Res (Camb); 2024; 2024():5549592. PubMed ID: 38586596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of COMT and PRODH gene variants with intelligence quotient (IQ) and executive functions in 22q11.2DS subjects.
    Carmel M; Zarchi O; Michaelovsky E; Frisch A; Patya M; Green T; Gothelf D; Weizman A
    J Psychiatr Res; 2014 Sep; 56():28-35. PubMed ID: 24853458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analyses of the associations between the genes of 22q11 deletion syndrome and schizophrenia.
    Arinami T
    J Hum Genet; 2006; 51(12):1037-1045. PubMed ID: 16969581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of COMT genotype on behavioral symptomatology in the 22q11.2 Deletion Syndrome.
    Bearden CE; Jawad AF; Lynch DR; Monterossso JR; Sokol S; McDonald-McGinn DM; Saitta SC; Harris SE; Moss E; Wang PP; Zackai E; Emanuel BS; Simon TJ
    Child Neuropsychol; 2005 Feb; 11(1):109-17. PubMed ID: 15846854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive correlates of a functional COMT polymorphism in children with 22q11.2 deletion syndrome.
    Shashi V; Keshavan MS; Howard TD; Berry MN; Basehore MJ; Lewandowski E; Kwapil TR
    Clin Genet; 2006 Mar; 69(3):234-8. PubMed ID: 16542388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.